Companies › ABVC

ABVC BIOPHARMA INC (ABVC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001173313 · EDGAR filings · Updated 2026-07-28

ABVC BIOPHARMA INC (ABVC) has reported institutional ownership of 3.2%, with 13 institutional managers holding positions valued at $792.1K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — PRE 14A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-02 — Current report (8-K) filed
• 2026-05-18 — Quarterly report (10-Q) filed
• 2026-05-15 — Late-filing notice for quarterly report (NT 10-Q)
• 2026-03-27 — POS AM filed
• 2026-03-27 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ABVC BIOPHARMA INC has 13 institutional holders and institutional ownership of 3.2%.

Data flags from SEC filings

Related companies

INTENSITY THERAPEUTICS INC (INTS) · Phio Pharmaceuticals Corp (PHIO) · CELLECTAR BIOSCIENCES INC (CLRB) · Cocrystal Pharma Inc (COCP) · ERNEXA THERAPEUTICS INC (ERNA) · INTELLIGENT BIO SOLUTIONS IN (INBS)